# Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study)

> **NCT05695495** · PHASE1 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** N,N-Dimethyltryptamine (5mg)
- **DRUG:** N,N-Dimethyltryptamine (10mg)
- **DRUG:** N,N-Dimethyltryptamine (15mg)
- **DRUG:** N,N-Dimethyltryptamine (20mg)
- **DRUG:** N,N-Dimethyltryptamine (25mg)
- **DRUG:** Placebo (saline)

## Key facts

- **NCT ID:** NCT05695495
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-12
- **Primary completion:** 2025-02-02
- **Final completion:** 2025-03-04
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05695495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05695495, "Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05695495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*